Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.15
AFAM's Cash to Debt is ranked higher than
62% of the 347 Companies
in the Global Medical Care industry.

( Industry Median: 0.20 vs. AFAM: 0.15 )
AFAM' s 10-Year Cash to Debt Range
Min: 0.03   Max: 41.79
Current: 0.15

0.03
41.79
Equity to Asset 0.64
AFAM's Equity to Asset is ranked higher than
87% of the 332 Companies
in the Global Medical Care industry.

( Industry Median: 0.41 vs. AFAM: 0.64 )
AFAM' s 10-Year Equity to Asset Range
Min: 0.21   Max: 0.83
Current: 0.64

0.21
0.83
Interest Coverage 17.17
AFAM's Interest Coverage is ranked higher than
77% of the 193 Companies
in the Global Medical Care industry.

( Industry Median: 6.13 vs. AFAM: 17.17 )
AFAM' s 10-Year Interest Coverage Range
Min: 0.01   Max: 271.75
Current: 17.17

0.01
271.75
F-Score: 6
Z-Score: 4.16
M-Score: -2.14
WACC vs ROIC
7.25%
5.47%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 4.97
AFAM's Operating margin (%) is ranked higher than
64% of the 348 Companies
in the Global Medical Care industry.

( Industry Median: 9.21 vs. AFAM: 4.97 )
AFAM' s 10-Year Operating margin (%) Range
Min: 0.01   Max: 15.41
Current: 4.97

0.01
15.41
Net-margin (%) 2.78
AFAM's Net-margin (%) is ranked higher than
67% of the 348 Companies
in the Global Medical Care industry.

( Industry Median: 4.59 vs. AFAM: 2.78 )
AFAM' s 10-Year Net-margin (%) Range
Min: -15.72   Max: 10.69
Current: 2.78

-15.72
10.69
ROE (%) 6.23
AFAM's ROE (%) is ranked higher than
65% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 10.46 vs. AFAM: 6.23 )
AFAM' s 10-Year ROE (%) Range
Min: -35.12   Max: 48.75
Current: 6.23

-35.12
48.75
ROA (%) 3.91
AFAM's ROA (%) is ranked higher than
72% of the 353 Companies
in the Global Medical Care industry.

( Industry Median: 4.18 vs. AFAM: 3.91 )
AFAM' s 10-Year ROA (%) Range
Min: -17.4   Max: 28.04
Current: 3.91

-17.4
28.04
ROC (Joel Greenblatt) (%) 53.48
AFAM's ROC (Joel Greenblatt) (%) is ranked higher than
89% of the 350 Companies
in the Global Medical Care industry.

( Industry Median: 17.58 vs. AFAM: 53.48 )
AFAM' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 0.02   Max: 216.77
Current: 53.48

0.02
216.77
Revenue Growth (3Y)(%) 13.00
AFAM's Revenue Growth (3Y)(%) is ranked higher than
87% of the 259 Companies
in the Global Medical Care industry.

( Industry Median: 8.50 vs. AFAM: 13.00 )
AFAM' s 10-Year Revenue Growth (3Y)(%) Range
Min: -16.3   Max: 35.4
Current: 13

-16.3
35.4
EBITDA Growth (3Y)(%) -8.70
AFAM's EBITDA Growth (3Y)(%) is ranked higher than
55% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 7.20 vs. AFAM: -8.70 )
AFAM' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -42.9   Max: 93.4
Current: -8.7

-42.9
93.4
EPS Growth (3Y)(%) -12.80
AFAM's EPS Growth (3Y)(%) is ranked higher than
57% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 8.30 vs. AFAM: -12.80 )
AFAM' s 10-Year EPS Growth (3Y)(%) Range
Min: -34.1   Max: 84
Current: -12.8

-34.1
84
» AFAM's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2014

AFAM Guru Trades in Q1 2014

Jim Simons 86,092 sh (New)
Chuck Royce 1,500 sh (-95.79%)
» More
Q2 2014

AFAM Guru Trades in Q2 2014

Chuck Royce 1,500 sh (unchged)
Jim Simons 73,347 sh (-14.80%)
» More
Q3 2014

AFAM Guru Trades in Q3 2014

Chuck Royce Sold Out
Jim Simons 17,900 sh (-75.60%)
» More
Q4 2014

AFAM Guru Trades in Q4 2014

Jim Simons Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with AFAM

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 29.90
AFAM's P/E(ttm) is ranked higher than
76% of the 407 Companies
in the Global Medical Care industry.

( Industry Median: 57.20 vs. AFAM: 29.90 )
AFAM' s 10-Year P/E(ttm) Range
Min: 4.48   Max: 322.11
Current: 29.9

4.48
322.11
Forward P/E 19.96
AFAM's Forward P/E is ranked higher than
77% of the 407 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. AFAM: 19.96 )
N/A
PE(NRI) 31.30
AFAM's PE(NRI) is ranked higher than
80% of the 407 Companies
in the Global Medical Care industry.

( Industry Median: 52.00 vs. AFAM: 31.30 )
AFAM' s 10-Year PE(NRI) Range
Min: 5.2   Max: 612
Current: 31.3

5.2
612
P/B 1.90
AFAM's P/B is ranked higher than
84% of the 407 Companies
in the Global Medical Care industry.

( Industry Median: 3.80 vs. AFAM: 1.90 )
AFAM' s 10-Year P/B Range
Min: 0.59   Max: 5.36
Current: 1.9

0.59
5.36
P/S 0.83
AFAM's P/S is ranked higher than
79% of the 407 Companies
in the Global Medical Care industry.

( Industry Median: 1.90 vs. AFAM: 0.83 )
AFAM' s 10-Year P/S Range
Min: 0.33   Max: 1.94
Current: 0.83

0.33
1.94
PFCF 77.20
AFAM's PFCF is ranked higher than
63% of the 407 Companies
in the Global Medical Care industry.

( Industry Median: 132.45 vs. AFAM: 77.20 )
AFAM' s 10-Year PFCF Range
Min: 2.42   Max: 147.06
Current: 77.2

2.42
147.06
POCF 65.70
AFAM's POCF is ranked higher than
62% of the 407 Companies
in the Global Medical Care industry.

( Industry Median: 22.00 vs. AFAM: 65.70 )
AFAM' s 10-Year POCF Range
Min: 2.38   Max: 116.98
Current: 65.7

2.38
116.98
EV-to-EBIT 20.34
AFAM's EV-to-EBIT is ranked higher than
79% of the 407 Companies
in the Global Medical Care industry.

( Industry Median: 30.37 vs. AFAM: 20.34 )
AFAM' s 10-Year EV-to-EBIT Range
Min: 2.3   Max: 25.3
Current: 20.34

2.3
25.3
Shiller P/E 19.50
AFAM's Shiller P/E is ranked higher than
94% of the 407 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. AFAM: 19.50 )
AFAM' s 10-Year Shiller P/E Range
Min: 5.77   Max: 739.5
Current: 19.5

5.77
739.5
Current Ratio 2.02
AFAM's Current Ratio is ranked higher than
85% of the 335 Companies
in the Global Medical Care industry.

( Industry Median: 1.34 vs. AFAM: 2.02 )
AFAM' s 10-Year Current Ratio Range
Min: 1.34   Max: 3.69
Current: 2.02

1.34
3.69
Quick Ratio 2.02
AFAM's Quick Ratio is ranked higher than
87% of the 335 Companies
in the Global Medical Care industry.

( Industry Median: 1.12 vs. AFAM: 2.02 )
AFAM' s 10-Year Quick Ratio Range
Min: 1.34   Max: 3.69
Current: 2.02

1.34
3.69
Days Sales Outstanding 55.13
AFAM's Days Sales Outstanding is ranked higher than
69% of the 407 Companies
in the Global Medical Care industry.

( Industry Median: 54.36 vs. AFAM: 55.13 )
AFAM' s 10-Year Days Sales Outstanding Range
Min: 43.04   Max: 99.28
Current: 55.13

43.04
99.28

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 1.10
AFAM's Price/DCF (Projected) is ranked higher than
92% of the 407 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. AFAM: 1.10 )
AFAM' s 10-Year Price/DCF (Projected) Range
Min: 0.36   Max: 2.92
Current: 1.1

0.36
2.92
Price/Median PS Value 1.20
AFAM's Price/Median PS Value is ranked higher than
75% of the 407 Companies
in the Global Medical Care industry.

( Industry Median: 1.40 vs. AFAM: 1.20 )
AFAM' s 10-Year Price/Median PS Value Range
Min: 0.17   Max: 2.3
Current: 1.2

0.17
2.3
Earnings Yield (Greenblatt) 5.30
AFAM's Earnings Yield (Greenblatt) is ranked higher than
72% of the 338 Companies
in the Global Medical Care industry.

( Industry Median: 4.40 vs. AFAM: 5.30 )
AFAM' s 10-Year Earnings Yield (Greenblatt) Range
Min: 3.9   Max: 42.6
Current: 5.3

3.9
42.6
Forward Rate of Return (Yacktman) -17.68
AFAM's Forward Rate of Return (Yacktman) is ranked higher than
54% of the 207 Companies
in the Global Medical Care industry.

( Industry Median: 11.24 vs. AFAM: -17.68 )
AFAM' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -17.7   Max: 53.9
Current: -17.68

-17.7
53.9

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, DVA, FSNUY, BDUUF, SKHCY » details
Traded in other countries:YCR.Germany,
Almost Family Inc was incorporated in Delaware in November 1985. The Company along with its subsidiaries is a regionally focused provider of home health services. The Company has two reportable segments: Visiting Nurse and Personal Care. Its Visiting Nurse segment provides Medicare-certified home health nursing services to patients in need of recuperative care, typically following a period of hospitalization or care in another type of inpatient facility. Its services are often provided to patients in lieu of additional care in other settings, such as long term acute care hospitals, inpatient rehabilitation hospitals or skilled nursing facilities. Its nurses, therapists, medical social workers and home health aides work closely with patients and their families to design and implement an individualized treatment response to a physician-prescribed plan of care. Under the umbrella of Senior Advocacy mission, it offer clinically-based protocols customized to meet the needs of the increasingly medically complex, chronic and co-morbid patient populations it serves such as Frail Elderly Care Management, Optimum Balance, Silver Steps, Cardiocare, Orthopedic and Urology. Its PC segment provides services in patients' homes on an as-needed, hourly basis. These services include personal care, medication management, meal preparation, caregiver respite and homemaking. Its services are often provided to patients who would otherwise be admitted to skilled nursing facilities for long term custodial care. It has service locations in Florida, Kentucky, Connecticut, New Jersey, Massachusetts, Missouri, Indiana, Illinois, Pennsylvania, Tennessee, Georgia, Mississippi and Alabama. Its competitors include: Amedisys, Inc., Gentiva Health Services, Inc., and LHC Group, Inc. The Company is subject to federal and state laws.
» More Articles for AFAM

Headlines

Articles On GuruFocus.com
comment on AFAM Apr 10 2013 
comment on AFAM Feb 28 2013 
comment on AFAM Feb 18 2013 
comment on AFAM Feb 15 2013 
comment on AFAM Oct 22 2012 
comment on AFAM Oct 11 2012 
comment on AFAM Jun 20 2012 
“Powerball” Ideas - Home Healthcare Companies: AFAM, GTIV, LHCG, AMED Jan 06 2012 
Almost Family: The Magic Formula Stock is getting cheaper and cheaper Dec 11 2011 
Magic Formula Stock: Amedisys (AMED) Aug 05 2011 


More From Other Websites
Quest Diagnostics' Pharyngitis Test Wins FDA Clearance - Analyst Blog Apr 16 2015
Chemed Poised on Balanced Growth, Roto-Rooter Business - Analyst Blog Apr 15 2015
Is Bruker Poised for Growth in NMR Amid Competition? - Analyst Blog Apr 14 2015
Almost Family (AFAM) Worth Watching: Stock Up 9% - Tale of the Tape Apr 14 2015
Merge Healthcare Up on New iConnect Business Unit Launch - Analyst Blog Apr 13 2015
Quest Diagnostics (DGX) Poised on Strong Fundamentals - Analyst Blog Apr 10 2015
Omnicell Settles Charges, Regains Nasdaq Compliance - Analyst Blog Apr 08 2015
Almost Family downgraded by Robert W. Baird Apr 08 2015
Home Health Care Stock Poised For An Explosive Breakout Apr 07 2015
AmSurg Poised on Strong Fundamentals, Strategic Buyouts - Analyst Blog Apr 06 2015
AmSurg Buys Halifax to Boost Anesthesia Services in Florida - Analyst Blog Apr 02 2015
LHC Group (LHCG) Looks Good: Stock Adds 6.5% in Session - Tale of the Tape Apr 02 2015
Almost Family (AFAM) Shares March Higher, Can It Continue? - Tale of the Tape Apr 01 2015
Almost Family (AFAM) Jumps: Stock Rises 6.1% - Tale of the Tape Mar 31 2015
Surgical Care Affiliates (SCAI) Falls: Stock Goes Down 5.1% - Tale of the Tape Mar 27 2015
HCA Holdings Scales 52-Week High on Solid Q4 Results - Analyst Blog Mar 24 2015
Omnicell Tweaks '15 View on Legal Issues, Impending Buyout - Analyst Blog Mar 18 2015
Integra (IART) Rides High on Solid Q4, DuraSeal Product Line - Analyst Blog Mar 18 2015
AAC Holdings (AAC) Catches Eye: Stock Up 6.2% in Session - Tale of the Tape Mar 16 2015
Why Almost Family (AFAM) Stock Might be a Great Pick - Tale of the Tape Mar 16 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK